SCHEMBL8457380

SCHEMBL8457380

CO[C@H]1O[C@@H](n2cnc3c(NC4CCCC4)ncnc32)C(O)C1O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 5/20 0.75
ADORA2A P29274 4/20 0.71
TSHR P16473 3/20 0.71
ADORA2B P29275 3/20 0.71
PMP22 Q01453 2/20 0.71
ADORA1 P30542 2/20 0.71
GAA P10253 1/20 0.71
HTT P42858 1/20 0.71
SIGMAR1 Q99720 1/20 0.71
SLC29A1 Q99808 1/20 0.71
RXFP1 Q9HBX9 1/20 0.71
MEN1 O00255 1/20 0.71
KMT2A Q03164 1/20 0.71
TP53 P04637 1/20 0.71
NFKB1 P19838 1/20 0.71
HIF1A Q16665 1/20 0.71
SMN1; SMN2 Q16637 1/20 0.70
TDP1 Q9NUW8 1/20 0.70
CYP2C19 P33261 1/20 0.70
THPO P40225 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10599439 0.87 ADORA3 (0.74) ADORA3ADORA2ATSHRADORA2BPMP22
SCHEMBL10599429 0.87 ADORA3 (0.74) ADORA3ADORA2ATSHRADORA2BPMP22
SCHEMBL12521617 0.87 ADORA3 (0.74) ADORA3ADORA2ATSHRADORA2BPMP22
SCHEMBL10602576 0.86 ADORA2A (0.74) ADORA3ADORA2ATSHRADORA2BPMP22
SCHEMBL14906549 0.86 ADORA3 (1.00) ADORA3ADORA2ATSHRADORA2BPMP22
SCHEMBL13268988 0.85 ADORA3 (0.98) ADORA3ADORA2ATSHRADORA2BPMP22
SCHEMBL15144299 0.84 ADORA3 (0.83) ADORA3ADORA2ATSHRADORA2BPMP22
SCHEMBL12355496 0.84 ADORA3 (0.83) ADORA3ADORA2ATSHRADORA2BPMP22
SCHEMBL14903061 0.84 ADORA3 (0.83) ADORA3ADORA2ATSHRADORA2BPMP22
SCHEMBL1298953 0.84 ADORA3 (0.74) ADORA3ADORA2ATSHRADORA2BPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097562-A1 Method for treating tension-type headache HEAD EXPLORER APS (DK) 2004-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097562-A1 Method for treating tension-type headache GRIN3A, GRIN2A, GRIK4 ADORA3 1052/4885ADORA2A 1031/4885TSHR 1186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.